JenaValve Appoints Dan Dearen to Board of Directors

IRVINE, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve...

Related Keywords

Germany ,Boston College ,Massachusetts ,United States ,Qatar ,Munich ,Bayern ,Boston ,California ,Fairbanks ,Irvine ,John Kilcoyne ,Dan Dearen ,Axonics Inc ,Bain Capital Life Sciences ,Southern Methodist University ,Qatar Investment Authority ,Jenavalve Technology Inc ,Peijia Medical ,Boston Scientific ,Valiance Life Sciences ,Miraval Holding ,Fairbanks Systems Group ,Company Trilogy ,Valve Technology ,Chief Financial Officer ,Chief Operating ,Financial Officer ,Vessix Vascular ,Medication Delivery Devices ,Ventana Growth ,Jenavalve Board ,Chief Executive ,Business Management ,Strategic Management ,Accredited Director ,Heart Valve System ,Trilogy System ,Breakthrough Device Designation ,Trilogy Heart Valve System ,Andera Partners ,Edmond De Rothschild Investment Partners ,Cormorant Asset Management ,Legend Capital ,Neomed Management ,Pictet Alternative Advisors ,Innovatus Capital Partners ,Jenavalve Technology ,Nc ,